Evidence map›Paper›PMID 34656523›Full record

ArticleThe Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

Prevalence of infection by human T Cell lymphotropic viruses (HTLV-1/2) in adult population in Vitória-ES.

Maria P S Orletti, Tatiane Assone, Glenia Daros Sarnaglia, Marina Lobato Martins, Carolina Rosadas, Jorge Casseb, Graham Taylor, Joaquim B Ferreira-Filho, Fausto E L Pereira, Angélica Espinosa Miranda

Open access · goldAbstract read
In one paragraph

Article in The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Human T-lymphotropic virus 2 (HTLV-2) prevalence of blood donors in the state of Pará, Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Maria P S OrlettiPrograma de Pós-Graduação em Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil.
Tatiane AssoneFaculdade de Medicina / Instituto de Medicina Tropical de São Paulo, Universidade de São Paulo, São Paulo, SP, Brasil; Ministério da Saúde, Secretaria de Vigilância em Saúde, Brasília, DF, Brasil. Electronic address: tatiane.assone@aids.gov.br.
Glenia Daros SarnagliaPrograma de Pós-Graduação em Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil.
Marina Lobato MartinsInterdisciplinary HTLV Research Group, Belo Horizonte, Minas Gerais, Brazil.
Carolina RosadasSection of Virology, Department of Infectious Disease, Imperial College London, London, United Kingdom.
Jorge CassebFaculdade de Medicina / Instituto de Medicina Tropical de São Paulo, Universidade de São Paulo, São Paulo, SP, Brasil.
Graham TaylorSection of Virology, Department of Infectious Disease, Imperial College London, London, United Kingdom.
Joaquim B Ferreira-FilhoPrograma de Pós-Graduação em Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil.
Fausto E L PereiraPrograma de Pós-Graduação em Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil.
Angélica Espinosa MirandaPrograma de Pós-Graduação em Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil; Ministério da Saúde, Secretaria de Vigilância em Saúde, Brasília, DF, Brasil. Electronic address: angelica.miranda@aids.gov.br.
Universidade Federal do Espírito Santo · BRImperial College London · GBUniversidade de São Paulo · BRMinistério da Saúde · ST

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBrazil has a high number of HTLV-1/2 infections which are unequally distributed in the country. Most prevalence studies have focused on specific populations, such as blood donors and pregnant women. Some areas, for example the state of Bahia, have robust information about HTLV-1/2 infection, however there is no information available about this infection in the general population of Vitória, Espírito Santo, Brazil.

objectiveTo determine the prevalence of HTLV-1/2 infection in adults from the municipality of Vitoria, ES.

methodsA cross sectional study was performed from September 2010 to December 2011, in individuals of both sexes, aged 18 or older living in Vitória-ES. Venous blood samples were collected and tested for anti-HTLV-1/2 antibodies by chemiluminescent immunoassay (CMIA). Individuals with CMIA reactive results were submitted to a new blood collection for retesting by CMIA, followed by PCR to confirm infection and discriminate the viral type.

resultsFrom 1502 tested samples, eight were reactive in CMIA and all were confirmed by PCR. Therefore, the prevalence of HTLV-1/2 was 0.53% (8/1502, 95% CI: 0.2-1.0%). The infection rate was 0.7% in men (5/711, 95% CI: 0.17-1.51%), and 0.38% in women (3/791, 95% CI: 0-0.81%).

conclusionsThe prevalence of HTLV-1/2 infection was 0.53% (8/1502; 95% CI: 0.2-0.9%). Confirmatory test using real-time PCR (qPCR) identified seven individuals positive for HTLV-1 and one for HTLV-2. Considering the risk of infected individuals to develop high morbidity and mortality diseases, it would be important to implement public health policies aimed at stopping transmission of these viruses in this municipality.

Indexed as

HTLV-II InfectionsHTLV-I InfectionsHuman T-lymphotropic virus 1AdultBrazilCross-Sectional StudiesFemaleHumansHuman T-lymphotropic virus 2MalePregnancyPrevalenceReal-Time Polymerase Chain ReactionT-LymphocytesBrazilGeneral PopulationHTLV-1HTLV-2PrevalenceVitória

Identifiers

PMID34656523
PMCPMC9392168
OpenAlexW3206843830

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.